Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Gets Second Chance At Sedasys Sedation Device Approval

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson subsidiary Ethicon Endo-Surgery has received a go-ahead from the FDA commissioner's office to embark on a rarely used process to appeal a PMA denial by the agency’s device center.
Advertisement

Related Content

Ethicon Gains PMA For SEDASYS; Opens New Opportunity In GI Medicine
News In Brief
J&J’s Sedasys Sedation Device Heads To FDA Appeals Panel Dec. 14
J&J’s Sedasys Sedation Device Heads To FDA Appeals Panel Dec. 14
Regulatory News In Brief
Regulatory News In Brief
News In Brief
J&J Appeals FDA "Not-Approvable" Letter For Sedasys Sedation System
J&J Appeals FDA "Not-Approvable" Letter For Sedasys Sedation System
J&J’s Computer-Assisted Sedation System Gets FDA Panel Nod

Topics

Advertisement
UsernamePublicRestriction

Register

MT029594

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel